North America Pelvic Floor Electric Stimulator Market - Industry Trends and Forecast to 2028

TABLE OF CONTENT

TABLE OF CONTENTS 1 INTRODUCTION 33 1.1 OBJECTIVES OF THE STUDY 33 1.2 MARKET DEFINITION 33 1.3 OVERVIEW OF NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET 33 1.4 LIMITATIONS 35 1.5 MARKETS COVERED 35 2 MARKET SEGMENTATION 37 2.1 MARKETS COVERED 37 2.2 GEOGRAPHICAL SCOPE 38 2.3 YEARS CONSIDERED FOR THE STUDY 39 2.4 CURRENCY AND PRICING 39 2.5 DBMR TRIPOD DATA VALIDATION MODEL 40 2.6 MULTIVARIATE MODELLING 43 2.7 PRODUCT TYPE LIFELINE CURVE 43 2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 44 2.9 DBMR MARKET POSITION GRID 45 2.10 MARKET APPLICATION COVERAGE GRID 46 2.11 VENDOR SHARE ANALYSIS 47 2.12 SECONDARY SOURCES 48 2.13 ASSUMPTIONS 48 3 EXECUTIVE SUMMARY 49 4 PREMIUM INSIGHTS 52 5 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET: REGULATIONS 53 5.1 U.S 53 5.2 EUROPE 54 5.3 CHINA 54 5.4 AUSTRALIA 55 6 MARKET OVERVIEW 56 6.1 DRIVERS 58 6.1.1 RISING GERIATRIC POPULATION 58 6.1.2 INCREASING PREVALENCE OF CHRONIC DISEASES 61 6.1.3 INTRODUCTION OF ADVANCE TECHNOLOGY BASED PELVIC FLOOR ELECTRIC STIMULATOR 63 6.1.4 RISING PER CAPITA INCOME 63 6.2 RESTRAINTS 64 6.2.1 HIGH COST OF PELVIC FLOOR ELECTRIC STIMULATOR 64 6.2.2 LACK OF AWARENESS 65 6.3 OPPORTUNITIES 65 6.3.1 INCREASING HEALTHCARE EXPENDITURE ACROSS THE WORLD 65 6.3.2 ADVANCEMENT IN HEALTHCARE INFRASTRUCTURE 67 6.3.3 STRATEGIC INITIATIVES BY KEY MARKET PLAYERS 68 6.4 CHALLENGES 68 6.4.1 LACK OF ACCESSIBILITY 68 6.4.2 STRINGENT REGULATION POLICY 69 7 IMPACT OF COVID-19 ON THE NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET 71 7.1 IMPACT ON PRICE 71 7.2 IMPACT ON DEMAND 71 7.3 IMPACT ON SUPPLY CHAIN 71 7.4 STRATEGIC DECISIONS FOR MANUFACTURERS 72 7.5 CONCLUSION 72 8 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY PRODUCT TYPE 73 8.1 OVERVIEW 74 8.2 MOBILE 77 8.2.1 HAND-HELD 77 8.2.2 TRANSPORTABLE 78 8.3 FIXED 78 8.3.1 TABLE-TOP 79 8.3.2 TROLLEY-FIXED 79 8.4 WEARABLE 79 9 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY DEVICE TYPE 80 9.1 OVERVIEW 81 9.2 NON-IMPLANTABLE ELECTRICAL STIMULATOR DEVICE 84 9.3 IMPLANTABLE ELECTRICAL STIMULATOR DEVICE 84 10 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY NUMBER OF CHANNELS 86 10.1 OVERVIEW 87 10.2 1 CHANNEL 90 10.3 2 CHANNEL 91 11 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY THERAPY 92 11.1 OVERVIEW 93 11.2 PHYSICAL THERAPY 96 11.3 OCCUPATIONAL THERAPY 97 12 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY TREATMENT 98 12.1 OVERVIEW 99 12.2 PELVIC FLOOR MUSCLE TRAINING (PFMT) 102 12.3 INTRAVAGINAL NEUROMUSCULAR ELECTRICAL STIMULATION (NMES) 103 12.4 TRANSCUTANEOUS TIBIAL NERVE STIMULATION (TTNS) 104 13 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY APPLICATION 105 13.1 OVERVIEW 106 13.2 URINARY INCONTINENCE 109 13.3 SEXUAL DYSFUNCTION 110 13.4 NEURODEGENERATIVE DISEASES 111 13.5 OTHERS 112 14 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY END USER 113 14.1 OVERVIEW 114 14.2 HOSPITALS 117 14.2.1 ACUTE CARE HOSPITALS 118 14.2.2 LONG-TERM CARE HOSPITALS 118 14.2.3 NURSING FACILITIES 118 14.2.4 REHABILITATION CENTERS 118 14.3 CLINICS 118 14.4 HOME-CARE SETTINGS 119 15 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY DISTRIBUTION CHANNEL 120 15.1 OVERVIEW 121 15.2 DIRECT TENDERS 124 15.3 THIRD PARTY DISTRIBUTION 125 15.4 OTHERS 126 16 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET, BY GEOGRAPHY 127 16.1 OVERVIEW 128 16.2 NORTH AMERICA 134 16.2.1 U.S. 141 16.2.2 CANADA 144 16.2.3 MEXICO 147 17 NORTH AMERICA PELVIC FLOOR ELECTRIC STIMULATOR MARKET: COMPANY LANDSCAPE 150 17.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 150 18 SWOT 151 19 COMPANY PROFILES 152 19.1 LABORIE, INC. 152 19.1.1 COMPANY SNAPSHOT 152 19.1.2 COMPANY SHARE ANALYSIS 152 19.1.3 PRODUCT PORTFOLIO 153 19.1.4 RECENT DEVELOPMENTS 153 19.2 UTAH MEDICAL PRODUCTS, INC. 154 19.2.1 COMPANY SNAPSHOT 154 19.2.2 REVENUE ANALYSIS 154 19.2.3 COMPANY SHARE ANALYSIS 155 19.2.4 PRODUCT PORTFOLIO 155 19.2.5 RECENT DEVELOPMENT 155 19.3 INCONTROL MEDICAL 156 19.3.1 COMPANY SNAPSHOT 156 19.3.2 COMPANY SHARE ANALYSIS 156 19.3.3 PRODUCT PORTFOLIO 157 19.3.4 RECENT DEVELOPMENTS 157 19.4 SHENZHEN XFT MEDICAL LIMITED 158 19.4.1 COMPANY SNAPSHOT 158 19.4.2 COMPANY SHARE ANALYSIS 158 19.4.3 PRODUCT PORTFOLIO 159 19.4.4 RECENT DEVELOPMENT 159 19.5 TIC MEDIZINTECHNIK GMBH & CO. KG 160 19.5.1 COMPANY SNAPSHOT 160 19.5.2 PRODUCT PORTFOLIO 160 19.5.3 RECENT DEVELOPMENT 160 19.6 ATLANTIC THERAPEUTICS 161 19.6.1 COMPANY SNAPSHOT 161 19.6.2 PRODUCT PORTFOLIO 161 19.6.3 RECENT DEVELOPMENT 161 19.7 CLEO 162 19.7.1 COMPANY SNAPSHOT 162 19.7.2 PRODUCT PORTFOLIO 162 19.7.3 RECENT DEVELOPMENT 162 19.8 EVERYWAY MEDICAL INSTRUMENTS CO., LTD 163 19.8.1 COMPANY SNAPSHOT 163 19.8.2 PRODUCT PORTFOLIO 163 19.8.3 RECENT DEVELOPMENT 163 19.9 GYMNAUNIPHY 164 19.9.1 COMPANY SNAPSHOT 164 19.9.2 PRODUCT PORTFOLIO 164 19.9.3 RECENT DEVELOPMENTS 164 19.10 NOVUQARE 165 19.10.1 COMPANY SNAPSHOT 165 19.10.2 PRODUCT PORTFOLIO 165 19.10.3 RECENT DEVELOPMENTS 165 19.11 RELEVIUM LABS INC. 167 19.11.1 COMPANY SNAPSHOT 167 19.11.2 PRODUCT PORTFOLIO 167 19.11.3 RECENT DEVELOPMENT 167 19.12 SUGAR INTERNATIONAL 168 19.12.1 COMPANY SNAPSHOT 168 19.12.2 PRODUCT PORTFOLIO 168 19.12.3 RECENT DEVELOPMENT 168 19.13 SUNMEDIX CO, LTD. 169 19.13.1 COMPANY SNAPSHOT 169 19.13.2 PRODUCT PORTFOLIO 169 19.13.3 RECENT DEVELOPMENT 169 19.14 THE PROMETHEUS GROUP 170 19.14.1 COMPANY SNAPSHOT 170 19.14.2 PRODUCT PORTFOLIO 170 19.14.3 RECENT DEVELOPMENT 170 19.15 VERITY MEDICAL LTD 171 19.15.1 COMPANY SNAPSHOT 171 19.15.2 PRODUCT PORTFOLIO 171 19.15.3 RECENT DEVELOPMENT 171 19.16 V2U HEALTHCARE 172 19.16.1 COMPANY SNAPSHOT 172 19.16.2 PRODUCT PORTFOLIO 172 19.16.3 RECENT DEVELOPMENTS 172 20 QUESTIONNAIRE 173 21 RELATED REPORTS 176